Form 4: Beyond Air CFO Douglas Quinton Larson Granted Stock Options

Douglas Quinton Larson, CFO of Beyond Air, Inc., was granted stock options to purchase 300,000 shares of common stock on March 20, 2024.

Summary

• On March 20, 2024, Douglas Quinton Larson, the Chief Financial Officer of Beyond Air, Inc. [XAIR], was granted stock options.
• These options allow him to purchase 300,000 shares of the company's common stock at an exercise price of $1.53 per share.
• The options vest in installments, starting with 25% on December 31, 2024, and the remainder vesting annually on December 31 for the following three years.
• The options expire on March 20, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed as a positive incentive for management.

Positives

• The granting of stock options to the CFO aligns his interests with those of the shareholders, incentivizing him to improve the company's performance.

Risks

• The vesting schedule could incentivize short-term decision-making to meet vesting milestones.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term growth.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Companies like Amgen, Gilead Sciences, and Biogen routinely use stock options to incentivize their executives.
• The vesting schedule and exercise price are typical for such grants, designed to reward long-term value creation.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning management's interests with their own.
• Employees may see this as a sign of confidence in the company's future.

Key Dates